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Hemophilia and Hemophiliacs*t
BY ARmAND J. QUICK, M.D., PH.D.
Department of Biochemistry
Marquette University School of Medicine
Milwaukee, Wisconsin

iFEW diseases have been dramatized as much as hemophilia. It has been
called the royal disease and also the "curse of the Hapsburg," although it is
doubtful whether any member of that family ever had the disease. To present
a true picture of hemophilia, it is necessary to divorce facts from fancy and to
consider this disease as any other clinical deviation from the normal.
Hemophilia is an inherited disease characterized by defective coagulation of
the blood which results in excessive and sometimes uncontrolled hemorrhage
after injury. To understand the cause of the disease, it should be stated that
for blood to clot at least eight separate constituents of the blood are required.
The lack of any one of them results in faulty clotting. In hemophilia, the substance called thromboplastinogen is deficient. The amount of this agent even
in normal blood is very small. It is probable that if one could isolate all the
thromboplastinogen that is in the total volume of circulating blood, the quantity would probably not exceed in weight that of one or two tablets of aspirin.
Yet, this small quantity is far in excess of the minimal requirement for normal
clotting. In moderately-mild hemophilia, a small but measurable amount of
thromboplastinogen is present in the blood, but this is only about one-half or
one per cent of the concentration in normal blood. In severe hemophilia, only
a trace of the clotting factor can be detected.
The hemophiliac is entirely normal except for his proneness to bleeding. Contrary to popular opinion, external bleeding is much less common than internal,
but the former attracts more attention. Any hemophiliac who bleeds several
weeks following the extraction of a tooth is sure to come to the attention of a
newspaper reporter. It is the internal type which is the more dangerous and
insidious. One could cite as illustrations many examples such as the following.
One hemophiliac recently fell on ice and ruptured presumably a small blood
vessel. In the course of a day or two, he poured about one-half of all his blood
into his upper thigh. He could have bled to death, paradoxically, without
spilling a drop of blood.
* Read at the 54th Annual Meeting, Medical Library Association, Milwaukee, Wisconsin,
May 16-20, 1955.
t This work was supported by a grant (H-1612 C7) from the National Heart Institute,
National Institutes of Health, United States Public Health Service.
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The loss of blood externally is rarely as serious as the swelling produced by
internal bleeding. Such a swelling may compress a nerve, thereby causing excruciating pain and sometimes even paralysis. A blood vessel may be similarly
compressed and this may have serious consequences, such as blocking the circulation which sometimes terminates in gangrene and the loss of a limb. Brain
hemorrhages, which usually occur after head injury, are often rapidly fatal.
Abdominal bleeding may pose a serious problem especially since it may simulate
an inflammatory process such as appendicitis.
The most troublesome and the most serious in its consequences are hemorrhages into joints. Few severe hemophiliacs escape them and many sustain
permanent joint deformities. This crippling effect constitutes one of the most
important considerations of hemophilia. Since nearly all bleeding in hemophilia
is caused by injury and since the knee and the elbow are the most vulnerable
to trauma, it is not surprising that these joints are most commonly involved.
Although no cure for hemophilia has been found nor probably ever will be
achieved (since a disease which has its roots in the very germ plasma is not
correctable by the machinations of man), it is remarkable how great the advances have been in the management of this disease. Part of this success has
come about by the education of parents on how to handle the hemophilic child.
By impressing the mother with the dangers of injury and stimulating her ingenuity, for instance in the use of sponge rubber, many a fall results in merely
a bounce and not a bump.
It is remarkable how much has been accomplished by the simple application
of cold and pressure to a fresh injury and how much more could be achieved if
that gospel could be spread to reach everyone entrusted with the care of a
hemophilic child. In the past, many well-intentioned mothers applied heat
sometimes (unfortunately, at the advice of a physician) and thereby accentuated the hemorrhage. MIany times a child may be spared a prolonged stay in
the hospital by aborting a hemorrhage with these simple means.
Only one specific means is available to treat hemophilic bleeding and that
is a transfusion of fresh human plasma or blood. By this means, thromboplastinogen, which normal plasma contains in relative abundance, can be elevated sufficiently in the hemophiliac to produce temporarily-sufficient normal
clotting to control bleeding. The active principle, thromboplastinogen, is not
stable and disappears on storage. Therefore, banked blood is of very little
value, but fortunately by freezing plasma its full potency can be preserved for
a longer period.
It has long been the dream to prepare the active antihemophilic principle in
concentrated form and to administer it in a manner similar to that of insulin
for diabetes. Unfortunately, a number of serious difficulties are encountered.
The material must be given directly into the blood stream, whereas insulin is
injected under the skin. Furthermore, no satisfactory source outside of human
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blood has as yet been established. As long as it can only be obtained from
human plasma, it is more economical to give plasma or whole blood directly
rather than to attempt isolating and concentrating the active substance,
thromboplastinogen. If one gives a hemophiliac a transfusion of one pint of
plasma, he obtains all the thromboplastinogen it contains, whereas if one attempts to concentrate it, one must consider the cost both for the labor to
produce it and the loss of material in the process. Another consideration enters
the picture, namely, the diabetic needs insulin daily, whereas even a severe
hemophiliac may not require a transfusion for periods of months or even years.
A daily injection could, therefore, be justified only as a prophylactic measure
with only partial assurance of effectiveness. It must be remembered, furthermore, that such injections may cause the development of a resistance to the
active principle, which is exceedingly serious since in such a condition the
patient will no longer respond to transfusions.
It seems clear that for the present the management of hemophilia should
remain essentially as it is now. The local treatment of fresh injuries as stated,
with recourse to transfusion when the need arises, is making it possible for
most hemophiliacs to lead a surprisingly normal life.
When one studies a large number of hemophiliac families and obtains their
pedigree, one is struck by the immutability of the hereditary pattern. Without
going into genetic technicalities, it may be stated that hemophilia is transmitted as a sex-linked recessive trait. That means that if a hemophiliac marries
a normal woman, all of his sons will be entirely normal, whereas all his daughters
will inherit the defect but will not be bleeders. They are called "carriers" or
conductors, for they in turn transmit the defect to half their sons and daughters.
The sons will be bleeders and the daughters again will be carriers. Statistically,
a carrier will have only one active bleeder to three non-bleeder children. As her
offspring marry, the ratio of bleeders to normals inher descendants progressively
TABLE I
Dilution of the Hereditary Defect in Hemophilia
If the hemophiliacs

Generation

Do marry

Do not marry

Bleeders

Carriers

Normal

Bleeders

1
12
.1.............
1
10
1
1
II ....................
42
X 3
1
HIII............
5
171
.1
|
IV .............1
11
690
1
1
V ....................

Carriers

Normal

2
1
12
3
56
5
........
240
11
992
21

* These figures are calculated on the theoretical supposition that every individual marries,
has 4 children, and that every carrier has one bleeder son and one carrier daughter.
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decreases as is shown by Table I. Such a process is called elimination of an
inherited defect by dilution. This explains why hemophilia is relatively uncommon and yet often appears without any obtainable positive family history.
It is both significant and interesting that the severity of hemophilia is the
same in all the affected members of any one family. The defect is quantitatively
transmitted from one generation to another. If the disease is mild, it will be so
in all the bleeders who have a common progenitor. So consistent is this finding
that it can be designated as a law.
Any hereditary disease has social implications, and hemophilia perhaps more
than any other disease demonstrates the impact of that statement. As is wellknown, Queen Victoria was a hemophilic carrier. Of her nine children, two
daughters were proven carriers and one son a bleeder. One granddaughter
brought the disease into the Bourbon family of Spain, another granddaughter to
the Romanoff family of Russia. The consequence of this is recorded in history.
A people will overlook tyranny, corruption, and stupidity in a royal family, but
a physical defect in the anointed is not tolerated. Curiously, the Encyclopaedia
Britannica fails even to mention that Queen Victoria was a carrier, but it is
certain that because of this inborn defect, she contributed greatly, although
entirely innocently, to the downfall of two dynasties and brought about or at
least hastened two revolutions that have changed the course of history.
Hemophilia spares neither royalty nor commoner and since the disease is
widely spread, especially in the white race, our population has many carriers,
many of whom are totally unaware of having this defect and to whom the birth
of a hemophilic child is completely unexpected. Fortunately, due to the genetic
dilution process already mentioned, the number of carriers has remained relatively small, particularly because few of the bleeders in the past married. Since
nearly all the affected males in a primitive society die early, the disease appears
to be much more rare than in more civilized people. Hemophilia in the Negro
until recently was found so rarely that when a case was discovered, it was considered worthy to be reported. As medical care of infants has improved, the incidence of hemophilia has sharply increased. Interestingly, the incidence of
hemophilia in Jews is apparently lower than in Gentiles, even though there is
evidence that the disease was in Jewish families at the time when the Talmud
was written. It seems likely that the rite of circumcision may have been responsible. The medical literature records a number of fatal bleedings following
circumcision and it is certain that the number of unrecorded cases of bleeding
is much larger.
Modern medicine has made it possible for the hemophiliac to live and to lead
a fairly normal life. It is natural that many desire to marry and many do and
have children. Since all of their daughters are carriers, the incidence of the
disease is greatly increased as shown in Table I. Thus, medicine by its success
in controlling hemophilic bleeding more effectively has created another social
problem-the increase of hemophilia in society.

